#49 - Michael Demurjian, Founder & CEO at Aspargo Laboratories
No se pudo agregar al carrito
Solo puedes tener X títulos en el carrito para realizar el pago.
Add to Cart failed.
Por favor prueba de nuevo más tarde
Error al Agregar a Lista de Deseos.
Por favor prueba de nuevo más tarde
Error al eliminar de la lista de deseos.
Por favor prueba de nuevo más tarde
Error al añadir a tu biblioteca
Por favor intenta de nuevo
Error al seguir el podcast
Intenta nuevamente
Error al dejar de seguir el podcast
Intenta nuevamente
#49 - Michael Demurjian, Founder & CEO at Aspargo Laboratories
-
Narrado por:
-
De:
Acerca de esta escucha
Join us on the latest episode! Our Guest: Michael Demurjian, Founder & CEO at Aspargo Laboratories.
What you'll get out of this episode:
- Aspargo tackles inefficiencies in pill-based drug delivery through innovative oral suspensions.
- The company’s patented technology improves absorption via buccal and GI routes.
- First commercial product, HisQ (oral spray sildenafil), delivers rapid ED treatment in just 10 minutes—even on a full stomach.
- Future products include sprays for weight loss and hair loss, launching via a telehealth platform.
- Upcoming smart dispenser connects with physicians and caregivers for enhanced adherence and monitoring.
To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/michael-demurjian-02868113/
Company LinkedIn https://www.linkedin.com/company/aspargo-laboratories-inc/
Website https://aspargolabs.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
Todavía no hay opiniones